There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Oxaliplatin (OXA)-induced carcinoembryonic antigen (CEA) surge was reported to be
associated with a clinical benefit. The aim of this study was to investigate the phenomenon
of CEA surge in irinotecan-based chemotherapy.